In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will leverage its early-stage drug discovery platform to ...

In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timelines by six to 12 months as the US looks to reclaim ...

It's time for Congress to bring stronger accountability to 340B and ensure that the program actually serves its intended ...

The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

An autoimmune disease diagnosis can mark the start of a difficult medical battle. But for too many patients, it also marks the beginning of a financial one. Many of the 50 million Americans living ...

Placing new limits on the 340B drug discount program would be a fresh challenge for hospitals as they confront funding cuts.

CMS plans to cut what Medicare pays hospitals for drugs bought through the 340B program and push site-neutral payment into a new category of outpatient services, two proposals that together would pull ...

The Centers for Medicare & Medicaid Services July 2 issued a proposed rule that would increase Medicare hospital outpatient ...

SPRINGFIELD, Ill. (WAND) — A plan heading to Gov. JB Pritzker's desk could help lower drug prices by regulating 340B contracts. The 340B drug pricing program was created in 1992 to improve access to ...

Illinois lawmakers passed a bill to protect hospitals' access to discounted drugs through the federal 340B program. A second bill was passed requiring an audit to see how hospitals and clinics use ...